FDA Clears Cepheid's GeneXpert Infinity-80 System | GenomeWeb

NEW YORK (GenomeWeb News) – Cepheid today announced the US Food and Drug Administration has cleared the GeneXpert Infinity-80 System in conjunction with its Xpert Flu test.

The GeneXpert Infinity-80 is a high-throughput, fully automated system designed to deliver around-the-clock results for various clinical testing applications, the Sunnyvale, Calif.-based company said. The system is designed to adapt to any workflow requirement including on-demand, batch, or STAT testing, and is available in configurations of 16, 24, 32, 40, 48, 56, 64, 72, and 80 modules.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.